Shivam Joshi

ORCID: 0000-0002-0558-6376
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Diet and metabolism studies
  • Dialysis and Renal Disease Management
  • Renal function and acid-base balance
  • Electrolyte and hormonal disorders
  • Agriculture Sustainability and Environmental Impact
  • Diabetes Treatment and Management
  • Muscle metabolism and nutrition
  • Potassium and Related Disorders
  • Nutritional Studies and Diet
  • Climate Change and Health Impacts
  • Diet, Metabolism, and Disease
  • Renal Transplantation Outcomes and Treatments
  • Muscle and Compartmental Disorders
  • Kidney Stones and Urolithiasis Treatments
  • Renal cell carcinoma treatment
  • Organ Donation and Transplantation
  • Metabolism and Genetic Disorders
  • Lung Cancer Diagnosis and Treatment
  • Renal and related cancers
  • Pediatric Urology and Nephrology Studies
  • Dietary Effects on Health
  • Sodium Intake and Health
  • COVID-19 and healthcare impacts
  • Obesity, Physical Activity, Diet
  • Renal and Vascular Pathologies

Orlando VA Medical Center
2023-2024

New York University
2019-2024

The Ohio State University
2024

The Ohio State University Wexner Medical Center
2024

Icahn School of Medicine at Mount Sinai
2022-2024

Bellevue Hospital Center
2019-2023

Orlando Health
2023

King George's Medical University
2023

University of Central Florida
2023

Florida College
2023

Although a longer time on dialysis before kidney transplant waitlisting has been shown for Blacks versus non-Blacks, relatively few studies have compared this outcome between Hispanics and Whites.A multivariable analysis of 1910 (684 Black, 452 Hispanic, 774 White) consecutive patients waitlisted at our center primary 2005 mid-2010 was performed from starting to (months), the percentage who were preemptively (waitlisted dialysis), after excluding patients.The variables associated with...

10.1097/tp.0b013e31827191d4 article EN Transplantation 2012-12-04

Our website uses cookies to enhance your experience. By continuing use our site, or clicking "Continue," you are agreeing Cookie Policy | Continue JAMA Internal Medicine HomeNew OnlineCurrent IssueFor Authors Podcast Publications Network Open Cardiology Dermatology Health Forum Neurology Oncology Ophthalmology Otolaryngology–Head & Neck Surgery Pediatrics Psychiatry Archives of (1919-1959) JN Learning / CMESubscribeJobsInstitutions LibrariansReprints Permissions Terms Use Privacy...

10.1001/jamainternmed.2019.2633 article EN JAMA Internal Medicine 2019-07-15

10.1053/j.ajkd.2022.08.013 article EN publisher-specific-oa American Journal of Kidney Diseases 2023-01-20

Background In adult kidney transplantation, there is no clear consensus on the incidence of graft failure-due-to noncompliance (GFNC), with some reporting it as relatively uncommon and others a major cause late failure. We suspected that GFNC was loss at our center but did not know extent this problem. Methods prospectively followed cohort 628 adult, primary kidney-alone transplant recipients long-term follow-up, other causes were determined from ongoing clinical evaluations. Using competing...

10.1097/01.tp.0000438199.76531.4a article EN Transplantation 2014-01-20

Chronic kidney disease (CKD) affects >10% of the adult population. Each year approximately 120,000 Americans develop end-stage kideny and initiate dialysis, which is costly associated with functional impairments, worse health-related quality life, high early-mortality rates exceeding 20% in first year. Recent declarations by World Kidney Day U.S. Government Executive Order seek to implement strategies that reduce burden failure slowing CKD progression controlling uremia without...

10.20944/preprints202005.0516.v1 preprint EN 2020-05-31

Chronic diseases are the leading cause of death and disability in United States, much this burden can be attributed to lifestyle behavioral risk factors. Lifestyle medicine is an approach preventing treating lifestyle-related chronic disease using evidence-based modification as a primary modality. NYC Health + Hospitals, largest municipal public health care system national pioneer incorporating systemwide. In 2019, pilot program was launched at Hospitals/Bellevue improve cardiometabolic...

10.1016/j.mayocpiqo.2024.01.005 article EN cc-by-nc-nd Mayo Clinic Proceedings Innovations Quality & Outcomes 2024-05-21

Glucagon-like peptide-1 (GLP-1) analogues aid weight loss that improves obesity-associated adipose tissue (AT) dysfunction. GLP-1 treatment may however also directly influence AT expresses the receptor (GLP-1R). The present study aimed to assess impact of analogue on subcutaneous (SCAT) inflammatory and fibrotic responses, compared with by calorie reduction (control). Among 39 participants Type 2 diabetes recruited, 30 age-matched were randomized 4 months Liraglutide (n=22) or restriction...

10.1042/cs20160803 article EN Clinical Science 2017-01-04

Sepsis survivors have greater healthcare use than those surviving hospitalizations for other reasons, yet factors associated with in this population remain ill-defined. Rural Americans are older, more chronic illnesses, and face unique barriers to access, which could affect postsepsis use. Therefore, we compared expenditures among rural urban sepsis survivors. We hypothesized that would expenditures.

10.1097/ccm.0000000000006397 article EN Critical Care Medicine 2024-08-13
Coming Soon ...